Skip to main content

Table 3 The results of heterogeneity analysis for SS on cancers

From: Causal associations of Sjögren’s syndrome with cancers: a two-sample Mendelian randomization study

 Cancer types

Cochran’s Q test

IVW (random)

Method

Q

Q pval

OR (95% CI)

P value

Overall breast cancer

MR Egger

64.3370

1.94E − 10

0.9952 (0.9649, 1.0264)

0.7595

IVW

65.1903

3.73E − 10

  

Luminal A-like breast cancer

MR Egger

27.1406

0.0013

1.0103 (0.9761, 1.0457)

0.5597

IVW

27.1431

0.0025

  

Luminal B/HER2-positive-like breast cancer

MR Egger

16.4500

0.0581

NE

NE

IVW

17.3952

0.0661

  

Luminal B/HER2-negative-like breast cancer

MR Egger

9.9122

0.3576

NE

NE

IVW

10.6899

0.3822

  

HER2-enriched-like breast cancer

MR Egger

8.2534

0.5088

NE

NE

IVW

8.6417

0.5664

  

Triple-negative breast cancer

MR Egger

8.9561

0.4413

NE

NE

IVW

8.9662

0.5353

  

Overall lung cancer

MR Egger

13.2712

0.1029

NE

NE

IVW

13.2712

0.1507

  

Lung adenocarcinoma

MR Egger

9.8468

0.2759

NE

NE

IVW

9.8716

0.3610

  

Squamous cell lung cancer

MR Egger

19.2431

0.0136

1.0343 (0.9198, 1.1631)

0.5731

IVW

22.0099

0.0088

  

Prostate cancer

MR Egger

8.7033

0.3679

NE

NE

IVW

15.8168

0.0708

  

Endometrial cancer

MR Egger

12.0095

0.2844

NE

NE

IVW

19.0442

0.0603

  

Lymphomas

MR Egger

29.8692

0.0009

1.0010 (1.0005, 1.0015)

0.0002

IVW

34.6995

0.0003

  

Liver and bile duct cancer

MR Egger

3.9196

0.8643

NE

NE

IVW

3.9221

0.9165

  

Cancer of urinary tract

MR Egger

18.8126

0.0427

0.9996 (0.9992, 1.0000)

0.0281

IVW

19.0671

0.0599

  

Thyroid cancer

MR Egger

8.2245

0.3132

NE

NE

IVW

8.9707

0.3448

  

Oral cavity and pharyngeal cancer

MR Egger

20.4960

0.0086

1.1068 (0.9445, 1.2970)

0.2098

IVW

25.2313

0.0027

  
  1. Abbreviations: CI confidence interval, IVW inverse variance weighted, MR Mendelian randomization, NE not estimate, OR odds ratio,  SS Sjögren’s syndrome